Brief: NeuBase Announces Acquisition Of Gene Modulating Technology From Vera
28/01/2021 16:43
Jan 28 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS ANNOUNCES ACQUISITION OF GENE
MODULATING
TECHNOLOGY FROM VERA THERAPEUTICS
* NEUBASE THERAPEUTICS INC - ACQUISITION INCLUDES
INTELLECTUAL
PROPERTY FOR PEPTIDE NUCLEIC ACID GENETIC MEDICINE PORTFOLIO
* NEUBASE THERAPEUTICS INC - FINANCIAL TERMS WERE NOT
DISCLOSED.
Source text for Eikon: ID:nGNX7qpJTz
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet